-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Beam Therapeutics Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2019 to 2024.
- Beam Therapeutics Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$99.7M, a 9.17% increase year-over-year.
- Beam Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$347M, a 133% decline from 2023.
- Beam Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$149M, a 762% decline from 2022.
- Beam Therapeutics Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $22.5M.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)